BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12013364)

  • 1. Atypical neuroleptic malignant syndrome associated with olanzapine.
    Reeves RR; Torres RA; Liberto V; Hart RH
    Pharmacotherapy; 2002 May; 22(5):641-4. PubMed ID: 12013364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome after the initiation of olanzapine.
    Levenson JL
    J Clin Psychopharmacol; 1999 Oct; 19(5):477-8. PubMed ID: 10505593
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A; Velikonja I
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A; Borkar HA; Chandak S
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome associated with olanzapine].
    García López MM; Ciprés L; de Cendra E; Vilalta Franch J
    Med Clin (Barc); 1999 Sep; 113(6):239. PubMed ID: 10472615
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
    Järventausta K; Leinonen E
    Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine-associated neuroleptic malignant syndrome.
    Norgard NB; Stark JE
    Pharmacotherapy; 2006 Aug; 26(8):1180-2. PubMed ID: 16863495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine-induced neuroleptic malignant syndrome.
    Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
    Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
    [No Abstract]   [Full Text] [Related]  

  • 10. Case report: possible neuroleptic malignant syndrome associated with olanzapine.
    Moltz DA; Coeytaux RR
    J Clin Psychopharmacol; 1998 Dec; 18(6):485-6. PubMed ID: 9864084
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
    Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR
    Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine-associated neuroleptic malignant syndrome.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Christodoulou NG; Paplos KG
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):897-902. PubMed ID: 12369263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A; Köster J; Schulz A; Krömker H; Becker T
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine induced "typical" neuroleptic malignant syndrome.
    Goveas JS; Hermida A
    J Clin Psychopharmacol; 2003 Feb; 23(1):101-2. PubMed ID: 12544383
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.
    Berry N; Pradhan S; Sagar R; Gupta SK
    Pharmacotherapy; 2003 Feb; 23(2):255-9. PubMed ID: 12587815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroleptic malignant syndrome after treatment with olanzapine].
    Emborg C
    Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroleptic malignant syndrome and atypical antipsychotics].
    Canora Lebrato J; Bermúdez García JM; Alvarez García ML; Rico Irles J
    Med Clin (Barc); 2000 Sep; 115(7):279. PubMed ID: 11013157
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome in a patient treated with olanzapine].
    Horni G; Meirik K; Lund MB
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome associated with olanzapine.
    Filice GA; McDougall BC; Ercan-Fang N; Billington CJ
    Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
    Stanfield SC; Privette T
    J Emerg Med; 2000 Nov; 19(4):355-7. PubMed ID: 11074330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.